WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 38  37  37  36  36  32  29  27 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Monaco)
Diphtheria
Japanese encephalitis
Measles
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Monaco)
Vaccine year result method % card seen                                                
BCG          100 
DTP1         
DTP3          100 
HepB_BD         
HepB3         
Hib3         
JapEnc         
MCV          100 
MCV2         
PCV1         
PCV3         
Pol3          100 
Rota1         
Rota_last         
Rubella1         
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Monaco)
BCG 89  89  89  89  89  97  99 
DTP1 99  99  99  99  99  99  99 
DTP3 99  99  99  99  99  99  99 
HepB3 99  99  99  99  99  99 
Hib3 99  99  99  99  99  99 
MCV 99  99  99  99  99  99  99 
PCV3
Pol3 99  99  99  99  99  99  99 
Rota_last


Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes Infant at risk
DTIPV 6 years; Yes
DTaPHibHepIPV ,, 4, 16-18 months; 0
DTaPHibIPV 3 months; Yes
DTaPIPV 11-13, 26-28 years; Yes
HPV 14 years; +2, +6 months
IPV 26-28 years; Yes
Influenza Infants and adults at risk
MMR 12, 13-24 months; Yes
MenC_conj 12 months;
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps population at risk
TdaPIPV 26-28 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total number of districts in country number              
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR              

Finance

Percentage of routine vaccines funded by Government From 0 to 100%              

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.